Vascular access challenges

Miller, Sheri

doi:10.1097/01.nurse.0000408482.28574.e4

Cited by 7 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The findings suggest 3 potential benefits of the PIVO blood collection device in comparison with classic venipunctures blood collection. First is the avoidance of painful venipunctures and their associated hematomas 17 and risks and costs of provider sharps injuries. 18 , 19 The study device exhibited nearly painless draws for patients.…”

Section: Discussionmentioning

confidence: 99%

A Novel Needle-Free Blood Draw Device for Sample Collection From Short Peripheral Catheters

Cadacio

Nachamkin

2017

Journal of Infusion Nursing

View full text Add to dashboard Cite

A new US Food and Drug Administration-cleared needleless blood collection device (PIVO; Velano Vascular, San Francisco, CA) for short peripheral catheters was compared with conventional venipuncture for collecting blood samples for routine laboratory analysis from adult healthy volunteers. The PIVO device was comparable with venipuncture in terms of providing high-integrity samples (no hemolysis or clotting), equivalent laboratory values, and better patient experience as assessed by pain scores. Further studies to assess the overall utility of the PIVO device are warranted.

show abstract

Section: Discussionmentioning

confidence: 99%

A Novel Needle-Free Blood Draw Device for Sample Collection From Short Peripheral Catheters

Cadacio

Nachamkin

2017

Journal of Infusion Nursing

View full text Add to dashboard Cite

show abstract

Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics

Ferrara

Zoupanou

Primiceri

et al. 2022

Biosensors and Bioelectronics

View full text Add to dashboard Cite

Liquid biopsy technologies have seen a significant improvement in the last decade, offering the possibility of reliable analysis and diagnosis from several biological fluids. The use of these technologies can overcome the limits of standard clinical methods, related to invasiveness and poor patient compliance. Along with this there are now mature examples of lab-on-chips (LOC) which are available and could be an emerging and breakthrough technology for the present and near-future clinical demands that provide sample treatment, reagent addition and analysis in a sample-in/answer-out approach. The possibility of combining non-invasive liquid biopsy and LOC technologies could greatly assist in the current need for minimizing exposure and transmission risks. The recent and ongoing pandemic outbreak of SARS-CoV-2, indeed, has heavily influenced all aspects of life worldwide. Ordinary tasks have been forced to switch from “in presence” to “distanced”, limiting the possibilities for a large number of activities in all fields of life outside of the home. Unfortunately, one of the settings in which physical distancing has assumed noteworthy consequences is the screening, diagnosis and follow-up of diseases. In this review, we analyse biological fluids that are easily collected without the intervention of specialized personnel and the possibility that they may be used -or not-for innovative diagnostic assays. We consider their advantages and limitations, mainly due to stability and storage and their integration into Point-of-Care diagnostics, demonstrating that technologies in some cases are mature enough to meet current clinical needs.

show abstract

Peripherally Inserted Central Catheter

Wojnar

Beaman

2013

Journal of Infusion Nursing

View full text Add to dashboard Cite

A randomized, retrospective chart review was conducted at a medium-sized community hospital to verify appropriateness of peripherally inserted central catheter (PICC) use in 49 inpatient patients. Study results support the Infusion Nurses Society recommendation to use PICCs to facilitate either short- or long-term intravenous therapy of vesicants, irritants, and any medications with a pH less than 5 or greater than 9 and osmolarity greater than 600 mOsm/L. All PICC insertion criteria recommended by the Centers for Disease Control and Prevention were met except one--the intended duration of intravenous therapy of more than 6 days. Identical PICC selection criteria are needed to standardize clinical practice.

show abstract

Vascular access challenges

Cited by 7 publications

References 1 publication

A Novel Needle-Free Blood Draw Device for Sample Collection From Short Peripheral Catheters

A Novel Needle-Free Blood Draw Device for Sample Collection From Short Peripheral Catheters

Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics

Peripherally Inserted Central Catheter

Contact Info

Product

Resources

About